Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/23/2025

Tick-Borne Illnesses Causing Gastrointestinal Symptoms

Clinical Presentation

  • The Centers for Disease Control and Prevention (CDC) reports that Ehrlichia chaffeensis infection (human monocytic ehrlichiosis) commonly presents with gastrointestinal manifestations including nausea (57%), vomiting (47%), and diarrhea (25%) 1
  • Abdominal pain, vomiting, and diarrhea are more common in children with ehrlichiosis than in adults 1
  • Symptoms of tick-borne diseases typically appear a median of 9 days (range: 5-14 days) after the bite of an infected tick 1
  • The CDC recommends considering geographic location, season, and presence of other symptoms when evaluating a patient with diarrhea following a tick bite 2

Tick-Borne Diseases

  • The primary vector for E. chaffeensis is the lone star tick (Amblyomma americanum) 2
  • Anaplasma phagocytophilum infection (human granulocytic anaplasmosis) can also cause gastrointestinal symptoms, though less frequently than ehrlichiosis 3
  • Patients with anaplasmosis typically seek medical care 4-8 days after fever onset 4
  • The primary vectors for anaplasmosis are Ixodes scapularis (blacklegged tick) in the northeastern and Midwestern United States and Ixodes pacificus (western blacklegged tick) along the West Coast 2

Diagnosis and Treatment

  • Tick-borne rickettsial diseases typically begin with fever, headache, malaise, and myalgia 4
  • Gastrointestinal symptoms may be prominent early in the course of illness, especially in ehrlichiosis 1
  • Early empiric therapy with doxycycline is the best way to prevent progression and reduce morbidity and mortality in tick-borne rickettsial diseases 1
  • Laboratory findings in the first week of illness may include leukopenia (low white blood cell count) 3, thrombocytopenia (low platelet count) 1, and elevated hepatic transaminase levels 3

Risk Factors

  • Increased severity of ehrlichiosis has been associated with advanced age (≥60 years) 2 and immunosuppression 3
  • The case-fatality rate for E. chaffeensis ehrlichiosis is approximately 3% 3